Guardant Health Inc

28 ott 2026, 22:51 UTC

Guardant Health, Inc. is trading lower in after-market hours, reflecting a decline in the broader market and now at its lowest level of the day.

27 ott 2026, 20:07 UTC

BTIG analyst Mark Massaro raised the price target on Guardant Health to $210 from $195, maintaining a Buy rating due to strong growth prospects.

26 ott 2026, 20:07 UTC

Guardant Health Inc is advancing today, reflecting a notable gain since Friday's close, with the stock remaining above its 20-day moving average.

22 ott 2026, 20:07 UTC

Guardant Health Inc shares are declining, reaching a low point around midday and closing significantly below Wednesday's close, remaining below its 20-day moving average.

21 ott 2026, 19:56 UTC

Guardant Health Inc shares are advancing, having earlier reached a peak before retracing, currently trading below the 20-day moving average.

20 ott 2026, 20:08 UTC

Guardant Health Inc will present 25 abstracts at the ESMO Congress 2026, focusing on advancements in circulating tumor DNA monitoring across various cancer types.

19 ott 2026, 20:07 UTC

Guardant Health Inc shares are lower amid legal pressures from a U.S. patent ruling affecting its Duplex Sequencing technology and recent test data release.

16 ott 2026, 20:02 UTC

Guardant Health Inc shares are declining following a recent loss in a DNA sequencing patent challenge against TwinStrand, marking its second setback in ongoing disputes.

15 ott 2026, 19:41 UTC

Guardant Health presents new data at the American College of Gastroenterology meeting, highlighting the effectiveness of its blood-based testing for colorectal cancer screening.

14 ott 2026, 19:31 UTC

Guardant Health Inc is rising amid a notable increase in the Health Care Services sector, with unusually high market volume today.

12 ott 2026, 20:07 UTC

Guardant Health Inc shares are declining, continuing a downward trend from Friday's close, reaching a session low before stabilizing near the lower end of its one-month range.

8 ott 2026, 20:07 UTC

Guardant Health Inc shares are declining amid a broader market downturn, reflecting ongoing pressures from rising mortgage rates and credit condition concerns.

7 ott 2026, 20:07 UTC

Shares of Guardant Health Inc declined despite Barclays raising the price target to $220.00 from $200.00, finishing significantly below their 20-day moving average.

6 ott 2026, 23:05 UTC

Guardant Health Inc is trading modestly lower in after-hours action, continuing a downward trend since Tuesday's close and remaining below its 20-day moving average.

5 ott 2026, 23:45 UTC

Guardant Health Inc's shares advanced in after-market hours, recovering from earlier declines and remaining significantly above the 20-day moving average.

2 ott 2026, 20:07 UTC

Guardant Health Inc is advancing amid a broadly higher market, supported by declining U.S. Treasury yields and recent labor statistics indicating potential economic challenges.

1 ott 2026, 19:15 UTC

Guardant Health Inc shares fell sharply after reaching an early high, hitting a low before 2 PM, though still above its 20-day moving average.

30 set 2026, 20:07 UTC

Guardant Health Inc is advancing during Wednesday's session, regaining ground after pulling back earlier, and remains above its 20-day moving average.

28 set 2026, 19:16 UTC

Guardant Health's Shield blood test is now covered for about 70 million Americans, yet shares are declining amid fluctuating trading activity.

24 set 2026, 19:35 UTC

Shares of Guardant Health Inc are trading lower despite social media attention on its new blood test for detecting common cancers, emphasizing early detection.

22 set 2026, 19:55 UTC

Guardant Health Inc shares are higher, reflecting positive trading activity and reaching a peak return earlier in the session, while remaining above its 20-day moving average.

21 set 2026, 23:06 UTC

Guardant Health Inc saw modest gains in after-market trading, remaining above its 20-day moving average and near the upper end of its one-month range.

18 set 2026, 22:11 UTC

Guardant Health Inc is gaining in after-market trading, reaching a peak return and remaining significantly above its 20-day moving average.

17 set 2026, 19:56 UTC

Guardant Health Inc is trading sharply higher, reaching its highest cumulative return since Wednesday and well above its 20-day moving average.

16 set 2026, 19:16 UTC

Guardant Health Inc is trading roughly flat, maintaining a slight range and positioned near the upper end of its one-month trading range.

15 set 2026, 23:31 UTC

Guardant Health Inc shares are lower in after-market hours, continuing a decline since Tuesday's close, with no specific news identified to explain the movement.

14 set 2026, 20:02 UTC

Guardant Health Inc shares are higher today, driven by unusually high trading volume, despite broader market concerns over rising crude oil prices and inflation.

11 set 2026, 20:08 UTC

Guardant Health Inc shares are lower today, continuing a trend since Thursday's close. The stock is trading below its 20-day moving average.

10 set 2026, 20:07 UTC

Guardant Health Inc shares are lower today, reflecting broader market declines. The stock peaked earlier but has since reached a session low.

8 set 2026, 20:08 UTC

Guardant Health recognized by Business Insider for innovation in biotechnology. Shares are lower today, pulling back from earlier session highs.